Partner Headlines - CLSN

  1. UPDATE: Celsion Slightly Falls Back Following Treatment News

    Benzinga
  2. Celsion Jumps On Interim Data On Cancer Drug

    Benzinga
  3. Morning Market Gainers

    Benzinga
  4. Benzinga's Top Initiations

    Benzinga
  5. Celsion Presents Preclinical Data For Its TheraSilence Platform ...

    Benzinga
  6. Morning Market Movers

    Benzinga
  7. Benzinga's M&A Chatter for Tuesday June 10, 2014

    Benzinga
  8. Celsion to Present Updated Overall Survival Results from HEAT ...

    Benzinga
  9. Celsion Says Recent Analysis Indicates ThermoDox Could Significantly ...

    Benzinga
  10. Mornings Movers for Feb. 28, 2014: CETV, OTVI, MELI, REGI, GALE ...

    Benzinga
  11. Celsion Announces $15M At-The-Market Registered Direct Offering ...

    Benzinga
  12. Morning Market Movers

    Benzinga
  13. Celsion Presents Combined Clinical Data from Two Phase I Trials ...

    Benzinga
  14. Celsion Announces Zhejiang HISUN Pharmaceutical does Not Plan ...

    Benzinga
  15. Stocks Hitting 52-Week Lows

    Benzinga
  16. Celsion Halted Wednesday, Says Will Host Conference Call Jan ...

    Benzinga
  17. Option Speculators Circle Celsion

    SchaeffersResearch
  18. Stocks Hitting 52-Week Highs

    Benzinga
  19. UPDATE: Dawson James Initiates Celsion at Market Outperform on ...

    Benzinga
  20. Celsion Corp Says Continuing Phase 2 Study

    Benzinga
  21. Celsion Corporation (CLSN) CEO Michael H Tardugno buys 5,000 ...

    GuruFocus
  22. Celsion Thermodox Gets Orphan Drug Status in US/Europe

    Benzinga
  23. Health Care Sector Wrap

    FoxBusiness
  24. Gap, General Motors Among Stocks Up on High Volume Friday

    FoxBusiness
  25. Call Volume Surges as Celsion Extends Its Rally

    SchaeffersResearch
  26. Celsion Announces Collaboration With the University of Oxford ...

    Benzinga
  27. Celsion Announces Resubmission With Philips Healthcare of Combined ...

    Benzinga
  28. Celsion Announces ThermoDox Commercial Supply Agreement With ...

    Benzinga
  29. Rodman & Renshaw Maintains Outperform on Celsion

    Benzinga
  30. Celsion Completes Consultative Review Process With EMA for Phase ...

    Benzinga
  31. Celsion Corp. (CLSN) CEO Michael H Tardugno buys 5,000 Shares

    GuruFocus
  32. Celsion Corp. (CLSN) CFO Gregory L Weaver buys 5,000 Shares

    GuruFocus
Trading Center